# Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy

> **NCT01520337** · — · COMPLETED · sponsor: **Cosmo Technologies Ltd** · enrollment: 170 (actual)

## Conditions studied

- Polyp and Adenoma Detection During Colonoscopy

## Interventions

- **DEVICE:** oral tablet dye for detection of polyps during colonoscopy

## Key facts

- **NCT ID:** NCT01520337
- **Lead sponsor:** Cosmo Technologies Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-03
- **Final completion:** 2013-10
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2014-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520337, "Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01520337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*